Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.
about
GH and the cardiovascular system: an update on a topic at heartSkeletal muscle aging: influence of oxidative stress and physical exercise.Sarcopenic obesity in aging population: current status and future directions for research.Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines.Skeletal muscle alterations in chronic heart failure: differential effects on quadriceps and diaphragm.Creatinine excretion rate, a marker of muscle mass, is related to clinical outcome in patients with chronic systolic heart failure.
P2860
Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.
@en
type
label
Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.
@en
prefLabel
Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.
@en
P2093
P2860
P1433
P1476
Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.
@en
P2093
Gerhard Schuler
Norman Mangner
Volker Adams
Yae Matsuo
P2860
P2888
P304
P356
10.1007/S12020-012-9767-Z
P577
2012-08-19T00:00:00Z